US reports third case of potential MERS virus

A third potential case of the dangerous Middle East Respiratory Virus (MERS), has been found in the United States, health authorities said Tuesday.

"Two of the 20 team members exposed to the confirmed MERS patient are showing symptoms," said Geo Morales, spokesman for the Orlando hospital where one infected patient was treated.

"One of the two has been admitted to the hospital but is in stable condition. The other was treated and discharged and is following precautions at home. All 20 team members have been tested and we are expecting those results within the next day or two," the spokesman added.

The second infected US patient was confirmed as such May 10. The man, 44, is a health care worker who resides and works in Saudi Arabia, who traveled by plane May 1 from Jeddah to London, England, then to Boston, Atlanta, and Orlando, officials from the Centers for Disease Control and Prevention told reporters.

The United States announced its first case earlier this month, a health care worker who had traveled to Riyadh at the end of April.

MERS causes fever, cough and shortness of breath, and can be lethal particularly among older people and those with pre-existing health problems.

Some 30 percent of the several hundred people infected with it have died, according to the US Centers for Disease Control and Prevention.

The virus first emerged in Saudi Arabia in 2012 and recent research has suggested it may originate in camels.

The vast majority of cases have been in Saudi Arabia, but MERS has also been found in 16 other countries. Most cases involved people who had recently traveled to Saudi Arabia.

Related Stories

MERS death toll in Saudi reaches 111 (Update)

date May 03, 2014

Saudi health authorities announced Saturday two new deaths from the MERS coronavirus, raising to 111 the number of fatalities since the disease appeared in the kingdom in September 2012.

Recommended for you

AAPM: Platelet-rich plasma offers short-term benefit

date 11 hours ago

(HealthDay)—For patients with facet joint arthropathy, platelet-rich plasma (PRP) has a short-term positive impact, according to a study presented at the annual meeting of the American Academy of Pain Medicine, ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.